These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 18261561

  • 21. Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study.
    Ruiz JC, Diekmann F, Campistol JM, Sanchez-Fructuoso A, Rivera C, Oliver J, Fernandez-Fresnedo G, Arias M.
    Transplant Proc; 2005 Nov; 37(9):3833-5. PubMed ID: 16386555
    [Abstract] [Full Text] [Related]

  • 22. Clinical implications of proteinuria in renal transplant recipients switching to rapamycin for chronic allograft dysfunction.
    Gutiérrez MJ, González E, Andrés A, Morales JM.
    Transplant Proc; 2009 Nov; 41(6):2348-50. PubMed ID: 19715916
    [Abstract] [Full Text] [Related]

  • 23. Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus-based therapy: a multivariate analysis of results at five years.
    Legendre C, Brault Y, Morales JM, Oberbauer R, Altieri P, Riad H, Mahony J, Messina M, Pussell B, Martínez JG, Lelong M, Burke JT, Neylan JF, Rapamune Maintenance Regimen Study Group.
    Clin Transplant; 2007 Nov; 21(3):330-6. PubMed ID: 17488381
    [Abstract] [Full Text] [Related]

  • 24. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
    Stephany BR, Boumitri M, Budev M, Alao B, Poggio ED.
    J Heart Lung Transplant; 2009 Jun; 28(6):564-71. PubMed ID: 19481016
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Sirolimus in chronic allograft nephropathy in pediatric recipients.
    Ibáñez JP, Monteverde ML, Diaz MA, Goldberg J, Turconi AF.
    Pediatr Transplant; 2007 Nov; 11(7):777-80. PubMed ID: 17910656
    [Abstract] [Full Text] [Related]

  • 29. Conversion from calcineurin inhibitors to sirolimus in kidney transplant recipients: a retrospective cohort study.
    Cardinal H, Froidure A, Dandavino R, Daloze P, Hébert MJ, Colette S, Boucher A.
    Transplant Proc; 2009 Oct; 41(8):3308-10. PubMed ID: 19857737
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [Abstract] [Full Text] [Related]

  • 32. The combination of sirolimus and cyclosporine does not delay initial renal graft function recovery.
    Hsu HJ, Tian YC, Chen YC, Lai BC, Fang JT, Yang CW, Wu MS.
    Ren Fail; 2008 Feb; 30(3):303-6. PubMed ID: 18350450
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine.
    Romagnoli J, Citterio F, Nanni G, Favi E, Tondolo V, Spagnoletti G, Salerno MP, Castagneto M.
    Transplant Proc; 2006 May; 38(4):1034-6. PubMed ID: 16757255
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Is sirolimus a safe alternative to reduce or eliminate calcineurin inhibitors in chronic allograft nephropathy in kidney transplantation?
    Lai WJ, Chiang YJ, Chen Y, Chu SH.
    Transplant Proc; 2004 Sep; 36(7):2056-7. PubMed ID: 15518744
    [Abstract] [Full Text] [Related]

  • 38. Conversion to sirolimus in renal transplant patients with tumors.
    Sánchez-Fructuoso A, Conesa J, Perez Flores I, Ridao N, Calvo N, Prats D, Rodríguez A, Barrientos A.
    Transplant Proc; 2006 Oct; 38(8):2451-2. PubMed ID: 17097964
    [Abstract] [Full Text] [Related]

  • 39. Sirolimus in pediatric renal transplantation.
    Ibáñez JP, Monteverde ML, Goldberg J, Diaz MA, Turconi A.
    Transplant Proc; 2005 Mar; 37(2):682-4. PubMed ID: 15848500
    [Abstract] [Full Text] [Related]

  • 40. Conversion to sirolimus for chronic allograft dysfunction: long-term results confirm predictive value of proteinuria.
    Diekmann F, Budde K, Slowinski T, Oppenheimer F, Fritsche L, Neumayer HH, Campistol JM.
    Transpl Int; 2008 Feb; 21(2):152-5. PubMed ID: 18005087
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.